title: New research and new guidelines for the treatment of hypertension: a report from the 17th European Meeting on Hypertension.
authors.affiliation: Prous Science Medical Information Department.
authors.forename: X
authors.initials: X
authors.lastname: Rabasseda
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019405:Cytochrome P-450 CYP11B2 / Q000037:antagonists & inhibitors; D004032:Diet; D019587:Dietary Supplements; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000628:therapy*; D048288:Imidazolines / Q000819:agonists; D017410:Practice Guidelines as Topic; D000092502:Renin Inhibitors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D019405:Cytochrome P-450 CYP11B2; D004232:Diuretics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D048288:Imidazolines; D000092502:Renin Inhibitors